tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Income Statement

Compare
25 Followers

Actuate Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Actuate Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Actuate Therapeutics, Inc.'s net income was $-5.41M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 25.16M$ 24.97M$ 20.21M
Depreciation and Amortization
$ 2.14M$ 272.85K$ 63.61K
EBITDA
$ -25.16M$ -24.43M$ -20.08M
Operating Income
$ -25.16M$ -24.97M$ -20.21M
Other Income/Expenses
$ -2.12M$ 229.21K$ 47.41K
Pretax Income
$ -27.28M$ -24.74M$ -20.16M
Net Income
$ -27.29M$ -24.74M$ -20.16M
Per Share Metrics
Basic EPS
$ -3.26$ -1.65$ -1.34
Diluted EPS
$ -3.26$ -1.65$ -1.34
Weighted Average Shares Outstanding
19.51M 15.03M 15.03M
Weighted Average Shares Outstanding (Diluted)
19.51M 15.03M 15.03M
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History